2024-09-08 14:17:43 +0300

Revance Therapeutics Announces FDA Approval Of DAXXIFY - Quick Facts

Logo Nasdaq
Nasdaq
By Rtt News

(RTTNews) - Revance Therapeutics, Inc. (RVNC) announced the FDA has approved DAXXIFY for injection for the temporary improvement of moderate to severe frown lines in adults. The approval was based on the data generated in the SAKURA phase 3 clinical trial program, which included more than 2,700 patients and approximately 4,200 treatments.

Mark Foley, CEO, said: Importantly, we are very pleased DAXXIFY's label includes data demonstrating the achievement of none or mild wrinkle severity based on investigator and subject assessments, as this provides the foundation for our marketing claims around duration of effect.

AD
AD

Shares of Revance Therapeutics are up 14% in pre-market trade on Thursday.

For More Such Health News, visit rttnews.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Continue read on nasdaq.com

AD
Logo Benzinga
Business / FinanceBy Business Wire2024-09-08 14:00:00 +0300
Approved label includes full 36-week efficacy data from Phase 3 SAKURA clinical program, positioning DAXXIFY as the first and only long-acting neuromodulator...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-08 14:10:08 +0300
Sept 7 (Reuters) - Revance Therapeutics RVNC.O said on Thursday it has received the U.S. Food and Drug Administration's approval for its injection to treat...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-19 14:10:57 +0300
(RTTNews) - Axsome Therapeutics, Inc. (AXSM) announced the FDA has approved AUVELITY extended-release tablets for the treatment of major depressive disorder...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-12 06:52:00 +0300
(RTTNews) - Daiichi Sankyo and AstraZeneca's (AZN, AZN.L) Enhertu (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult...

Logo Nasdaq
Business / FinanceBy Rtt News2024-09-06 15:59:39 +0300
(RTTNews) - Spero Therapeutics, Inc. (SPRO) Tuesday announced that after the recent Type A meeting with FDA, the company is discussing resubmission of the...

Logo Nasdaq
Business / FinanceBy Rtt News2024-09-01 15:49:04 +0300
(RTTNews) - Finch Therapeutics Group, Inc. (FNCH) announced plans to reduce its workforce by approximately 37%. As part of the ongoing review, the company...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-23 17:00:31 +0300
(RTTNews) - Northwest Biotherapeutics has received approval from the UK Medicines and Healthcare Products Regulatory Agency for the company's Pediatric...

Logo Nasdaq
MarketsBy Rtt News2024-09-06 16:12:59 +0300
(RTTNews) - Moleculin Biotech, Inc. (MBRX) announced the FDA has granted Orphan Drug Designation of WP1122 for the treatment of Glioblastoma Multiforme....

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-16 13:24:53 +0300
(RTTNews) - Revive Therapeutics Ltd. issued an update on the phase 3 trial to evaluate the safety and efficacy of Bucillamine in patients with mild to...

Logo Nasdaq
Business / FinanceBy Rtt News2024-09-06 16:36:05 +0300
(RTTNews) - GSK plc (GSK, GSK.L) said the FDA will convene a meeting of the Cardiovascular and Renal Drugs Advisory Committee to review the New Drug...

Logo Nasdaq
Business / FinanceBy Rtt News2024-09-06 15:41:25 +0300
(RTTNews) - Eiger BioPharmaceuticals, Inc. (EIGR) issued an update on the status of its planned request for emergency use authorization of peginterferon...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-23 15:52:48 +0300
(RTTNews) - Bristol Myers Squibb Canada reported Health Canada's approval of OPDIVO 360 mg in combination with platinum-doublet chemotherapy every three...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-25 12:05:10 +0300
(RTTNews) - IVERIC bio, Inc. (ISEE), a biopharmaceutical company developing treatments for retinal diseases, expects to announce topline data from its...

Logo Nasdaq
Business / FinanceBy Rtt News2024-09-03 05:16:12 +0300
(RTTNews) - Novavax Inc. (NVAX) said that Swissmedic, the Swiss Agency for Therapeutic Products, has expanded its temporary authorization of Nuvaxovid...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-30 09:25:43 +0300
(RTTNews) - AstraZeneca PLC (AZN.L, AZN) said the detailed results from the DELIVER phase III trial showed the company's Farxiga significantly reduced the...

Logo Nasdaq
MarketsBy Rtt News2024-08-30 08:50:16 +0300
(RTTNews) - The U.S. Food and Drug Administration has accepted for priority review the Biologics License Application (BLA) for efanesoctocog alfa (BIVV001)...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-23 14:40:03 +0300
(RTTNews) - Synlogic, Inc. (SYBX) announced the FDA has granted Fast Track designation to SYNB1353 for the potential treatment of homocystinuria. SYNB1353,...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-11 08:52:19 +0300
(RTTNews) - Roche (RHHBY) announced US Food and Drug Administration approval of a label expansion for the VENTANA MMR RxDx Panel. The Panel helps identify...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-15 15:24:02 +0300
(RTTNews) - Biotechnology company Novavax, Inc. (NVAX) announced Monday that it submitted an application to the U.S. Food and Drug Administration (FDA) for...

Logo Nasdaq
Business / FinanceBy Rtt News2024-08-23 16:15:17 +0300
(RTTNews) - Abbott (ABT) announced the FDA has approved its new Proclaim Plus spinal cord stimulation system which gives physicians the ability to treat...